Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a monoclonal antibody for the treatment of osteoporosis.
Choose your region
Selecting a region may change the language and promotional content you see on the Adobe Stock web site.